{"id":708,"date":"2014-12-17T01:40:14","date_gmt":"2014-12-17T01:40:14","guid":{"rendered":"https:\/\/blogs.bmj.com\/jmg\/?p=708"},"modified":"2026-02-25T19:34:22","modified_gmt":"2026-02-25T19:34:22","slug":"mendelian-randomization-applied-to-drug-development-in-cardiovascular-disease-a-review","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/jmg\/2014\/12\/17\/mendelian-randomization-applied-to-drug-development-in-cardiovascular-disease-a-review\/","title":{"rendered":"Mendelian Randomization Applied to Drug Development in Cardiovascular Disease: A Review (Contributed by Lauren E Mokry)"},"content":{"rendered":"

Observational epidemiology has implicated a wide range of biomarkers in the onset of human disease, however given that these methods are prone confounding it becomes difficult to identify causal biomarkers deserving of pharmaceutical intervention. Mendelian randomization (MR) is an emerging technique in human genetics which utilizes the power of random assignment of genetic information at meiosis to determine whether a biomarker is causal in human disease. It has been suggested that this technique can help guide drug development and inevitably improve the delivery of new drugs to clinical care. In this article we review examples of MR studies in cardiovascular disease and discuss limitations in the technique\u2019s ability to predict therapeutic success in humans. (http:\/\/jmg.bmj.com\/content\/early\/2014\/12\/16\/jmedgenet-2014-102438<\/a> )<\/p>\n","protected":false},"excerpt":{"rendered":"

Observational epidemiology has implicated a wide range of biomarkers in the onset of human disease, however given that these methods are prone confounding it becomes difficult to identify causal biomarkers deserving of pharmaceutical intervention. Mendelian randomization (MR) is an emerging technique in human genetics which utilizes the power of random assignment of genetic information at […]<\/p>\n

Read More…<\/a><\/p>\n","protected":false},"author":123,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-708","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"\nMendelian Randomization Applied to Drug Development in Cardiovascular Disease: A Review (Contributed by Lauren E Mokry) - JMG Contact blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/jmg\/2014\/12\/17\/mendelian-randomization-applied-to-drug-development-in-cardiovascular-disease-a-review\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mendelian Randomization Applied to Drug Development in Cardiovascular Disease: A Review (Contributed by Lauren E Mokry) - JMG Contact blog\" \/>\n<meta property=\"og:description\" content=\"Observational epidemiology has implicated a wide range of biomarkers in the onset of human disease, however given that these methods are prone confounding it becomes difficult to identify causal biomarkers deserving of pharmaceutical intervention. Mendelian randomization (MR) is an emerging technique in human genetics which utilizes the power of random assignment of genetic information at [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/jmg\/2014\/12\/17\/mendelian-randomization-applied-to-drug-development-in-cardiovascular-disease-a-review\/\" \/>\n<meta property=\"og:site_name\" content=\"JMG Contact blog\" \/>\n<meta property=\"article:published_time\" content=\"2014-12-17T01:40:14+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-25T19:34:22+00:00\" \/>\n<meta name=\"author\" content=\"hqqu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HuiQiQu\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hqqu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2014\\\/12\\\/17\\\/mendelian-randomization-applied-to-drug-development-in-cardiovascular-disease-a-review\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2014\\\/12\\\/17\\\/mendelian-randomization-applied-to-drug-development-in-cardiovascular-disease-a-review\\\/\"},\"author\":{\"name\":\"hqqu\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\"},\"headline\":\"Mendelian Randomization Applied to Drug Development in Cardiovascular Disease: A Review (Contributed by Lauren E Mokry)\",\"datePublished\":\"2014-12-17T01:40:14+00:00\",\"dateModified\":\"2026-02-25T19:34:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2014\\\/12\\\/17\\\/mendelian-randomization-applied-to-drug-development-in-cardiovascular-disease-a-review\\\/\"},\"wordCount\":139,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2014\\\/12\\\/17\\\/mendelian-randomization-applied-to-drug-development-in-cardiovascular-disease-a-review\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2014\\\/12\\\/17\\\/mendelian-randomization-applied-to-drug-development-in-cardiovascular-disease-a-review\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2014\\\/12\\\/17\\\/mendelian-randomization-applied-to-drug-development-in-cardiovascular-disease-a-review\\\/\",\"name\":\"Mendelian Randomization Applied to Drug Development in Cardiovascular Disease: A Review (Contributed by Lauren E Mokry) - JMG Contact blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\"},\"datePublished\":\"2014-12-17T01:40:14+00:00\",\"dateModified\":\"2026-02-25T19:34:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2014\\\/12\\\/17\\\/mendelian-randomization-applied-to-drug-development-in-cardiovascular-disease-a-review\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2014\\\/12\\\/17\\\/mendelian-randomization-applied-to-drug-development-in-cardiovascular-disease-a-review\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2014\\\/12\\\/17\\\/mendelian-randomization-applied-to-drug-development-in-cardiovascular-disease-a-review\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mendelian Randomization Applied to Drug Development in Cardiovascular Disease: A Review (Contributed by Lauren E Mokry)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"name\":\"JMG Contact blog\",\"description\":\"JMG Contact blog\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\",\"name\":\"JMG Contact blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"width\":300,\"height\":34,\"caption\":\"JMG Contact blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\",\"name\":\"hqqu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"caption\":\"hqqu\"},\"description\":\"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.\",\"sameAs\":[\"https:\\\/\\\/x.com\\\/HuiQiQu\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/author\\\/hqiqu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mendelian Randomization Applied to Drug Development in Cardiovascular Disease: A Review (Contributed by Lauren E Mokry) - JMG Contact blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/jmg\/2014\/12\/17\/mendelian-randomization-applied-to-drug-development-in-cardiovascular-disease-a-review\/","og_locale":"en_US","og_type":"article","og_title":"Mendelian Randomization Applied to Drug Development in Cardiovascular Disease: A Review (Contributed by Lauren E Mokry) - JMG Contact blog","og_description":"Observational epidemiology has implicated a wide range of biomarkers in the onset of human disease, however given that these methods are prone confounding it becomes difficult to identify causal biomarkers deserving of pharmaceutical intervention. Mendelian randomization (MR) is an emerging technique in human genetics which utilizes the power of random assignment of genetic information at [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/jmg\/2014\/12\/17\/mendelian-randomization-applied-to-drug-development-in-cardiovascular-disease-a-review\/","og_site_name":"JMG Contact blog","article_published_time":"2014-12-17T01:40:14+00:00","article_modified_time":"2026-02-25T19:34:22+00:00","author":"hqqu","twitter_card":"summary_large_image","twitter_creator":"@HuiQiQu","twitter_misc":{"Written by":"hqqu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/jmg\/2014\/12\/17\/mendelian-randomization-applied-to-drug-development-in-cardiovascular-disease-a-review\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2014\/12\/17\/mendelian-randomization-applied-to-drug-development-in-cardiovascular-disease-a-review\/"},"author":{"name":"hqqu","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b"},"headline":"Mendelian Randomization Applied to Drug Development in Cardiovascular Disease: A Review (Contributed by Lauren E Mokry)","datePublished":"2014-12-17T01:40:14+00:00","dateModified":"2026-02-25T19:34:22+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2014\/12\/17\/mendelian-randomization-applied-to-drug-development-in-cardiovascular-disease-a-review\/"},"wordCount":139,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/jmg\/2014\/12\/17\/mendelian-randomization-applied-to-drug-development-in-cardiovascular-disease-a-review\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/jmg\/2014\/12\/17\/mendelian-randomization-applied-to-drug-development-in-cardiovascular-disease-a-review\/","url":"https:\/\/blogs.bmj.com\/jmg\/2014\/12\/17\/mendelian-randomization-applied-to-drug-development-in-cardiovascular-disease-a-review\/","name":"Mendelian Randomization Applied to Drug Development in Cardiovascular Disease: A Review (Contributed by Lauren E Mokry) - JMG Contact blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#website"},"datePublished":"2014-12-17T01:40:14+00:00","dateModified":"2026-02-25T19:34:22+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2014\/12\/17\/mendelian-randomization-applied-to-drug-development-in-cardiovascular-disease-a-review\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/jmg\/2014\/12\/17\/mendelian-randomization-applied-to-drug-development-in-cardiovascular-disease-a-review\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/jmg\/2014\/12\/17\/mendelian-randomization-applied-to-drug-development-in-cardiovascular-disease-a-review\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/jmg\/"},{"@type":"ListItem","position":2,"name":"Mendelian Randomization Applied to Drug Development in Cardiovascular Disease: A Review (Contributed by Lauren E Mokry)"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/jmg\/#website","url":"https:\/\/blogs.bmj.com\/jmg\/","name":"JMG Contact blog","description":"JMG Contact blog","publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/jmg\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/jmg\/#organization","name":"JMG Contact blog","url":"https:\/\/blogs.bmj.com\/jmg\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","contentUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","width":300,"height":34,"caption":"JMG Contact blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b","name":"hqqu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","caption":"hqqu"},"description":"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.","sameAs":["https:\/\/x.com\/HuiQiQu"],"url":"https:\/\/blogs.bmj.com\/jmg\/author\/hqiqu\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/708","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/users\/123"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/comments?post=708"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/708\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/media?parent=708"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/categories?post=708"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/tags?post=708"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}